Skip to main content
GLMD
NASDAQ Life Sciences

Aramchol Shows 3-4x Cell Death vs Enzalutamide in Prostate Cancer Models

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.515
Mkt Cap
$4.322M
52W Low
$0.411
52W High
$1.65
52W Position info
25% above low
Off High info
69% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

GLMD sits 25% above its 52-week low of $0.411 on light trading volume (0.1× avg).

Summary

Galmed disclosed first-time preclinical results showing Aramchol combined with enzalutamide produced a 3-4 fold increase in prostate cancer cell death versus enzalutamide alone. This is a new indication for Aramchol, which has been primarily studied in liver disease and Parkinson's. The data could expand the drug's addressable market and attract partnership interest, though it remains early-stage. The company recently completed a 1-for-8 reverse split effective August 19 to regain Nasdaq compliance, and this news may support the stock's post-split valuation. Next steps would be confirmation in animal models and potential IND-enabling studies.

At the time of this announcement, GLMD was trading at $0.51 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.3M. The 52-week trading range was $0.41 to $1.65. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

GLMD - Latest Insights

GLMD
Sep 08, 2026, 6:08 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $4.30
Real-time Price: $4.66 info
Change: +$0.360 (+8%) info
Market Cap: $4.822M info
GLMD
Sep 02, 2026, 4:20 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $4.12
Real-time Price: $4.66 info
Change: +$0.541 (+13%) info
Market Cap: $4.822M info
GLMD
Aug 19, 2026, 7:05 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.513
Real-time Price: $4.66 info
Change: Reverse Stock Split info
Market Cap: $4.822M info
GLMD
Aug 17, 2026, 9:20 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.5206
Real-time Price: $4.66 info
Change: Reverse Stock Split info
Market Cap: $4.822M info
GLMD
Aug 14, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.490
Real-time Price: $4.66 info
Change: Reverse Stock Split info
Market Cap: $4.822M info